Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response

Conclusion:CFH is implicated in nAMD patient treatment response to ranibizumab.Ophthalmologica
Source: Ophthalmologica - Category: Opthalmology Source Type: research